Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy

BACKGROUND: Developing the ability to use tumor-directed therapies to trigger potentially therapeutic immune responses against cancer antigens remains a high priority for cancer immunotherapy. We hypothesized that histotripsy, a novel non-invasive, non-thermal ablation modality that uses ultrasound-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Qu, Shibin, Worlikar, Tejaswi, Felsted, Amy E, Ganguly, Anutosh, Beems, Megan V, Hubbard, Ryan, Pepple, Ashley L, Kevelin, Alicia A, Garavaglia, Hannah, Dib, Joe, Toma, Mariam, Huang, Hai, Tsung, Allan, Xu, Zhen, Cho, Clifford Suhyun
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Clinical/Translational Cancer Immunotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057529/
https://ncbi.nlm.nih.gov/pubmed/31940590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars